Filing Details

Accession Number:
0001209191-15-000384
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-02 21:30:27
Reporting Period:
2014-12-30
Filing Date:
2015-01-02
Accepted Time:
2015-01-02 21:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251213 Ron Bentsur C/O Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York NY 10022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-30 200,000 $14.11 717,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Reflects the weighted average sale price. The range of prices for such transaction is $14.00 to $14.29.
  2. Includes 26,070 shares of restricted stock. In addition, Mr. Bentsur holds stock options to purchase up to 1,002,932 shares of Keryx common stock.